Medication Development for Addictive Disorders: The State of the Science
Vocci et al.
Am. J. Psychiatry 2005;162:1432-1440.
ABSTRACT
| FULL TEXT
Methadone: applied pharmacology and use as adjunctive treatment in chronic pain
Brown et al.
Postgrad. Med. J. 2004;80:654-659.
ABSTRACT
| FULL TEXT
The Gap Between Research and Practice in Substance Abuse Treatment
Marinelli-Casey et al.
Psychiatr. Serv. 2002;53:984-987.
ABSTRACT
| FULL TEXT
Developmental Toxicity of Levo-Alpha-Acetylmethadol (LAAM) in Tolerant Rats
York et al.
International Journal of Toxicology 2002;21:147-159.
ABSTRACT
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson et al.
NEJM 2000;343:1290-1297.
ABSTRACT
| FULL TEXT
Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor and Fiellin
ANN INTERN MED 2000;133:40-54.
ABSTRACT
| FULL TEXT
Relative Potency of levo-alpha -Acetylmethadol and Methadone in Humans under Acute Dosing Conditions
Eissenberg et al.
J. Pharmacol. Exp. Ther. 1999;289:936-945.
ABSTRACT
| FULL TEXT
Moderate- vs High-Dose Methadone in the Treatment of Opioid Dependence: A Randomized Trial
Strain et al.
JAMA 1999;281:1000-1005.
ABSTRACT
| FULL TEXT
Therapeutic Alliance and Psychiatric Severity as Predictors of Completion of Treatment for Opioid Dependence
Petry and Bickel
Psychiatr. Serv. 1999;50:219-227.
ABSTRACT
| FULL TEXT
Induction With Levomethadyl Acetate: Safety and Efficacy
Jones et al.
Arch Gen Psychiatry 1998;55:729-736.
ABSTRACT
| FULL TEXT
Clinical trials in psychiatry: background and statistical perspective
Johnson
Stat Methods Med Res 1998;7:209-234.
ABSTRACT
Intravenous and Oral l-alpha -Acetylmethadol: Pharmacodynamics and Pharmacokinetics in Humans
Walsh et al.
J. Pharmacol. Exp. Ther. 1998;285:71-82.
ABSTRACT
| FULL TEXT
The Involvement of Cytochrome P450 3A4 in the N-Demethylation of l-alpha -Acetylmethadol (LAAM), norLAAM, and Methadone
Moody et al.
Drug Metab. Dispos. 1997;25:1347-1353.
ABSTRACT
| FULL TEXT
Dose-Related Efficacy of Levomethadyl Acetate for Treatment of Opioid Dependence: A Randomized Clinical Trial
Eissenberg et al.
JAMA 1997;277:1945-1951.
ABSTRACT
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling et al.
Arch Gen Psychiatry 1996;53:401-407.
ABSTRACT
Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review
Farrell et al.
BMJ 1994;309:997-1001.
FULL TEXT
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson et al.
JAMA 1992;267:2750-2755.
ABSTRACT
Methadone Treatment and Acquired Immunodeficiency Syndrome
Cooper
JAMA 1989;262:1664-1668.
ABSTRACT
Alternative Induction and Crossover Schedules for Methadyl Acetate
Ling et al.
Arch Gen Psychiatry 1984;41:193-199.
ABSTRACT
Methadyl Acetate (LAAM) in the Treatment of Heroin Addicts: II. Double-blind Comparison of Gradual and Abrupt Detoxification
Judson et al.
Arch Gen Psychiatry 1983;40:834-840.
ABSTRACT
Withdrawal From Heroin in Three or Six Weeks: Comparison of Methadyl Acetate and Methadone
Sorensen et al.
Arch Gen Psychiatry 1982;39:167-171.
ABSTRACT
Long-term Follow-up of Clients of High- and Low-Dose Methadone Programs: Dr McGlothlin died shortly after this article was accepted. For the field and for many colleagues it is a loss that is keenly felt.--ED.
McGlothlin and Anglin
Arch Gen Psychiatry 1981;38:1055-1063.
ABSTRACT
A Cooperative Clinical Study of Methadyl Acetate: II. Friday-Only Regimen
Ling et al.
Arch Gen Psychiatry 1980;37:908-911.
ABSTRACT
Restabilization With Methadone After Methadyl Acetate Maintenance
Ling et al.
Arch Gen Psychiatry 1980;37:194-196.
ABSTRACT
Human Pharmacology and Abuse Potential of the Analgesic Buprenorphine: A Potential Agent for Treating Narcotic Addiction
Jasinski et al.
Arch Gen Psychiatry 1978;35:501-516.
ABSTRACT
A Cooperative Clinical Study of Methadyl Acetate: I. Three-Times-a-Week Regimen
Ling et al.
Arch Gen Psychiatry 1978;35:345-353.
ABSTRACT